Apolipoprotein CI knock-out mice display impaired memory functions

Journal of Alzheimer's Disease

Volumn 23, Issue 4, 2011, Pages 737-747

  Berbée, Jimmy F P ^a,b,c,e   Abildayeva, Karlygash ^c   Blokland, Arjan ^c   Jansen, Paula J ^c   Lütjohann, Dieter ^b   Gautier, Thomas ^d   Sijbrands, Eric ^e   Prickaerts, Jos ^c   Hadfoune, M'Hamed ^c   Ramaekers, Frans C S ^c   Kuipers, Folkert ^d   Rensen, Patrick C N ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BONN   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

APOC1; apolipoprotein C I; cholesterol; cognition and brain; memory

Indexed keywords

APOLIPOPROTEIN C1; APOLIPOPROTEIN E4; BRAIN PROTEIN; FATTY ACID; MESSENGER RNA; STEROL; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DISEASE; CELL ACTIVATION; CELL STRESS; COGNITION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GLIA CELL; KNOCKOUT MOUSE; LEARNING; LEARNING DISORDER; LIPID METABOLISM; MEMORY; MEMORY DISORDER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RECOGNITION; RISK ASSESSMENT; RISK FACTOR; WILD TYPE;

EID: 79953272165     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100576     Document Type: Article

References (82)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of lipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. (Pubitemid 23275809)
2. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472. (Pubitemid 23230526)
3. Takei N, Miyashita A, Tsukie T, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kimura H, Kakita A, Takahashi H, Tsuji S, Kanazawa I, Ihara Y, Odani S, Kuwano R (2009) Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics 93, 441-448.
4. Kamino K, Yoshiiwa A, Nishiwaki Y, Nagano K, Yamamoto H, Kobayashi T, Nonomura Y, Yoneda H, Sakai T, Imagawa M, Miki T, Ogihara T (1996) Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster. Gerontology 42 Suppl 1, 12-19. (Pubitemid 26183970)
5. Mullan M, Scibelli P, Duara R, Fallin D, Gold M, Schinka J, Hoyne J, Osborne A, Sevush S, Crawford F (1996) Famil-ial and population-based studies of apolipoprotein E and Alzheimer's disease. Ann N Y Acad Sci 802, 16-26. (Pubitemid 27055495)
6. Poduslo SE, Neal M, Herring K, Shelly J (1998) The apolipoprotein CI A allele as a risk factor for Alzheimer's disease. Neurochem Res 23, 361-367. (Pubitemid 28109881)
7. Poduslo SE, Neal M, Schwankhaus J (1995) A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease. Neurosci Lett 201, 81-83.
8. Scacchi R, Gambina G, Ruggeri M, Martini MC, Ferrari G, Silvestri M, Schiavon R, Corbo RM (1999) Plasmalevels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci Lett 259, 33-36. (Pubitemid 29051535)
9. Schellenberg GD, Boehnke M, Wijsman EM, Moore DK, Martin GM, Bird TD (1992) Genetic association and link-age analysis of the apolipoprotein CII locus and familial Alzheimer's disease. Ann Neurol 31, 223-227.
10. Nagelkerken L, Verzaal P, Lagerweij T, Persoon-Deen C, Berbee JF, Prens EP, Havekes LM, Oranje AP (2008) Development of atopic dermatitis in mice transgenic for human apolipoprotein C1. J Invest Dermatol 128, 1165-1172. (Pubitemid 351543217)
11. Bartres-Faz D, Junque C, Clemente IC, Serra-Grabulosa JM, Guardia J, Lopez-Alomar A, Sanchez-Aldeguer J, Mercader JM, Bargallo N, Olondo M, MoralP (2001) MRI and genetic correlates of cogniti ve function in elders with memory impair-ment. Neurobiol Aging 22, 449-459. (Pubitemid 32510918)
12. Serra-Grabulosa JM, Salgado-Pineda P, Junque C, Sole-Padulles C, Moral P, Lopez-Alomar A, Lopez T, Lopez-Guillen A, Bargallo N, Mercader JM, Clemente IC, Bartres-Faz D (2003) Apolipoproteins E and C1 and brain morphology in memory impaired elders. Neurogenetics 4, 141-146. (Pubitemid 36612197)
13. Abildayeva K, Berbee JF, Blokland A, Jansen PJ, Hoek FJ, Meijer O, Lutjohann D, Gautier T, Pillot T, De Vente J, Havekes LM, Ramaekers FC, Kuipers F, Rensen PC, Mulder M (2008) Human apolipoprotein CI expression in mice impairs learning and memory functions. J Lipid Res 49(4), 856-869.
14. Belloir B, Kovari E, Surini-Demiri M, Savioz A (2001) Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J Neurosci Res 64, 61-69. (Pubitemid 32267994)
15. Kalman J, McConathy W, Araoz C, Kasa P, Lacko AG (2000) Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res 22, 330-336. (Pubitemid 30409586)
16. Lidstrom AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, Blennow K (1998) Clusterin (apolipoprotein J) protein lev-els are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp Neurol 154, 511-521. (Pubitemid 29044220)
17. Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, Milne R, Rassart E (1998) Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem 71, 1643-1650. (Pubitemid 28443037)
18. Yamada T, Kondo A, Takamatsu J, Tateishi J, Goto I (1995) Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease. J Neurol Sci 129, 56-61.
19. Yamagata K, Urakami K, Ikeda K, Ji Y, Adachi Y, Arai H, Sasaki H, Sato K, Nakashima K (2001) High expres-sion of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease. Dement Geriatr CognDisord 12, 57-62. (Pubitemid 32149708)
20. Navarro A, Del Valle E, Astudillo A, Gonzalez del Rey C, Tolivia J (2003) Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Exp Neurol 184, 697-704. (Pubitemid 38182798)
21. Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI (2005) Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Neurobiol Dis 20, 574-582. (Pubitemid 41476283)
22. Koudinov AR, Berezov TT, Koudinova NV (2001) The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cere-brospinal fluid: implication for brain cholesterol pathology? Neurosci Lett 314, 115-118. (Pubitemid 33043780)
23. Martin-Rehrmann MD, Hoe HS, Capuani EM, Rebeck GW (2005) Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain. Neurotox Res 7, 231-242.
24. Vanmierlo T, Bloks VW, van Vark-van der Zee LC, Rutten K, Kerksiek A, Friedrichs S, Sijbrands E, Steinbusch HW, Kuipers F, Lutjohann D, Mulder M (2010) Alterations in brain cholesterol metabolism in the APPSLxPS1mut mouse, a model for Alzheimer's disease. J Alzheimers Dis 19, 117-127.
25. Vanmierlo T, Rutten K, Dederen J, Bloks VW, van Vark-van der Zee LC, Kuipers F, Kiliaan A, Blokland A, Sijbrands EJ, Steinbusch H, Prickaerts J, Lutjohann D, Mulder M (2009) Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol Aging, in press.
26. Lukiw WJ, Pappolla M, Pelaez RP, Bazan NG (2005) Alzheimer's disease-a dysfunction in cholesterol and lipid metabolism. Cell Mol Neurobiol 25, 475-483. (Pubitemid 41186260)
27. Reiss AB (2005) Cholesterol and apolipoprotein E in Alzheimer's disease. Am J Alzheimers Dis Other Demen 20, 91-96. (Pubitemid 40547349)
28. Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, Aid S, Poumes-Ballihaut C, Champeil-Potokar G, Lavialle M (2004) Polyunsaturated fatty acids in the cen-tral nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev 44, 509-538. (Pubitemid 40309154)
29. Lane RM, Farlow MR (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 46, 949-968.
30. Poirier J (2005) Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol Aging 26, 355-361. (Pubitemid 40082719)
31. van der Hoogt CC, Berbee JF, Espirito Santo SM, Gerritsen G, Krom YD, van der Zee A, Havekes LM, van Dijk KW, Rensen PC (2006) Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice. Biochim Biophys Acta 1761(2), 213-220.
32. Jong MC, Dahlmans VE, van Gorp PJ, van Dijk KW, Breuer ML, Hofker MH, Havekes LM (1996) In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J Clin Invest 98, 2259-2267. (Pubitemid 26394199)
33. Jong MC, Gijbels MJ, Dahlmans VE, Gorp PJ, Koopman SJ, Ponec M, Hofker MH, Havekes LM (1998) Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpress-ing human apolipoprotein C1. J Clin Invest 101, 145-152. (Pubitemid 28058913)
34. Conde-Knape K, Bensadoun A, Sobel JH, Cohn JS, Shachter NS (2002) Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase. J Lipid Res 43, 2136-2145. (Pubitemid 35471082)
35. Jong MC, Hofker MH, Havekes LM (1999) Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 19, 472-484. (Pubitemid 29135144)
36. Sehayek E, Eisenberg S (1991) Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem 266, 18259-18267. (Pubitemid 21908074)
37. Weisgraber KH, Mahley RW, Kowal RC, Herz J, Goldstein JL, Brown MS (1990) Apolipoprotein C-I modulates the interac-tion of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J Biol Chem 265, 22453-22459. (Pubitemid 120014322)
38. Soutar AK, Garner CW, Baker HN, Sparrow JT, Jackson RL, Gotto AM, Smith LC (1975) Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry 14, 3057-3064.
39. Havel RJ, Fielding CJ, Olivecrona T, Shore VG, Fielding PE, Egelrud T (1973) Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources. Biochemistry 12, 1828-1833.
40. Berbee JF, van der Hoogt CC, Sundararaman D, Havekes LM, Rensen PC (2005) Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL. J Lipid Res 46, 297-306. (Pubitemid 40271094)
41. Kinnunen PK, Ehnolm C (1976) Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase. FEBS Lett 65, 354-357.
42. Gautier T, Masson D, de Barros JP, Athias A, Gambert P, Aunis D, Metz-Boutigue MH, Lagrost L (2000) Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity. J Biol Chem 275, 37504-37509. (Pubitemid 32004858)
43. Dumont L, Gautier T, de Barros JP, Laplanche H, Blache D, Ducoroy P, Fruchart J, Fruchart JC, Gambert P, Masson D, Lagrost L (2005) Molecular mechanism of the blockade of plasma cholesteryl ester transfer protein by its physiological inhibitor apolipoprotein CI. J Biol Chem 280, 38108-38116. (Pubitemid 41642426)
44. de Haan W, Out R, Berbee JF, van der Hoogt CC, van Dijk KW, van Berkel TJ, Romijn JA, Jukema JW, Havekes LM, Rensen PC (2008) Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. Biochem Biophys Res Commun377, 1294-1298.
45. Steen H, Kolmakova A, Stuber M, Rodriguez ER, Gao F, Chatterjee S, Lima JA (2007) MRI visualized neo-intimal dissection and co-localization of novel apoptotic markers apolipoprotein C-1, ceramide and caspase-3 in a Watanabe hyperlipidemic rabbit model. Atherosclerosis 191, 82-89. (Pubitemid 46227432)
46. Berbee JF, Van Der Hoogt CC, Kleemann R, Schippers EF, Kitchens RL, van Dissel JT, Bakker-Woudenberg IA, Havekes LM, Rensen PC (2006) Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. FASEB J20, 2162-2164.
47. Westerterp M, Berbee JF, Pires NM, van Mierlo GJ, Kleemann R, Romijn JA, Havekes LM, Rensen PC (2007) Apolipopro-tein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation 116, 2173-2181. (Pubitemid 350060355)
48. Lauer SJ, Walker D, Elshourbagy NA, Reardon CA, Levy-Wilson B, Taylor JM (1988) Two copies of the human apolipoprotein C-I gene are linked closely to the apolipopro-tein E gene. J Biol Chem 263, 7277-7286.
49. Jong MC, van Ree JH, Dahlmans VE, Frants RR, Hofker MH, Havekes LM (1997) Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice. Biochem J 321 (Pt 2), 445-450. (Pubitemid 27056493)
50. van Ree JH, Hofker MH, van den Broek WJ, van Deursen JM, van der Boom H, Frants RR, Wieringa B, Havekes LM (1995) Increased response to cholesterol feeding in apolipoprotein C1-deficient mice. Biochem J 305 (Pt 3), 905-911.
51. Bronikowski AM, CarterPA, Swallow JG, GirardIA, Rhodes JS, Garland T Jr (2001) Open-field behavior of house mice selectively bred for high voluntary wheel-running. Behav Genet 31, 309-316. (Pubitemid 33021071)
52. Sik A, van Nieuwehuyzen P, Prickaerts J, Blokland A (2003) Performance of different mouse strains in an object recogni-tion task. Behav Brain Res 147, 49-54. (Pubitemid 37491412)
53. Rutten K, Vente JD, Sik A, Ittersum MM, Prickaerts J, Blokland A (2005) The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices. Behav Brain Res 164, 11-16. (Pubitemid 41253727)
54. Mulder M, Blokland A, van den Berg DJ, Schulten H, Bakker AH, Terwel D, Honig W, de Kloet ER, Havekes LM, Steinbusch HW, de Lange EC (2001) Apolipoprotein E pro-tects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging. Lab Invest 81, 953-960. (Pubitemid 32645971)
55. Jansen PJ, Lutjohann D, Abildayeva K, Vanmierlo T, Plosch T, Plat J, von Bergmann K, Groen AK, Ramaekers FC, Kuipers F, Mulder M (2006) Dietary plant sterols accumulate in the brain. BiochimBiophys Acta 1761, 445-453. (Pubitemid 43776461)
56. Lutjohann D, Brzezinka A, Barth E, Abramowski D, Staufenbiel M, von Bergmann K, Beyreuther K, Multhaup G, Bayer TA (2002) Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J Lipid Res 43, 1078-1085. (Pubitemid 34760879)
57. Thelen KM, Rentsch KM, Gutteck U, Heverin M, Olin M, Andersson U, von Eckardstein A, Bjorkhem I, Lutjohann D (2006) Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J Pharmacol Exp Ther316, 1146-1152. (Pubitemid 43345288)
58. Heid CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res 6, 986-994. (Pubitemid 26388091)
59. Plosch T, Kok T, Bloks VW, Smit MJ, Havinga R, Chimini G, Groen AK, Kuipers F (2002) Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem 277, 33870-33877.
60. de Waard MC, van der Pluijm I, Zuiderveen Borgesius N, Comley LH, Haasdijk ED, Rijksen Y, Ridwan Y, Zondag G, Hoeijmakers JH, Elgersma Y, Gillingwater TH, Jaarsma D. Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice. Acta Neuropathol 120, 461-475.
61. Vlug AS, Teuling E, Haasdijk ED, French P, Hoogenraad CC, Jaarsma D (2005) ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation. Eur J Neurosci 22, 1881-1894. (Pubitemid 41579379)
62. Masson D, Pais de Barros JP, Zak Z, Gautier T, Le Guern N, Assem M, Chisholm JW, Paterniti JR Jr, Lagrost L (2006) Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes. J Lipid Res 47, 356-365. (Pubitemid 43276921)
63. Westerterp M, de Haan W, Berbee JF, Havekes LM, Rensen PC (2006) Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL. J Lipid Res 47, 1203-1211. (Pubitemid 43830712)
64. Oitzl MS, Mulder M, Lucassen PJ, Havekes LM, Grootendorst J, de Kloet ER (1997) Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res 752, 189-196. (Pubitemid 27143913)
65. Raber J, Wong D, Yu GQ, Buttini M, Mahley RW, Pitas RE, Mucke L (2000) Apolipoprotein E and cognitive performance. Nature 404, 352-354. (Pubitemid 30164327)
66. Mak PA, Laffitte BA, Desrumaux C, Joseph SB, Curtiss LK, Mangelsdorf DJ, Tontonoz P, Edwards PA (2002) Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J Biol Chem 277, 31900-31908. (Pubitemid 34968998)
67. Grootendorst J, Bour A, Vogel E, Kelche C, Sullivan PM, Dodart JC, Bales K, Mathis C (2005) Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav Brain Res159, 1-14. (Pubitemid 40410579)
68. Atcliffe BW, MacRaild CA, Gooley PR, Howlett GJ (2001) The interaction of human apolipoprotein C-I with sub-micellar phospholipid. Eur J Biochem 268, 2838-2846. (Pubitemid 32862966)
69. Jonas A, Sweeny SA, Herbert PN (1984) Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin: cholesterol acyltransferase. J Biol Chem 259, 6369-6375. (Pubitemid 14108182)
70. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, Carothers A, Whalley L J (2002) Cognitive change and the APOE epsilon 4 allele. Nature 418, 932. (Pubitemid 34976020)
71. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, Visscher PM, Tynan MC, Whalley LJ (2004) Apolipoprotein e gene variability and cognitive functions at age 79: a follow-up of the Scottish mental survey of 1932. Psychol Aging 19, 367-371. (Pubitemid 38720884)
72. Deary IJ, Wright AF, Harris SE, Whalley LJ, Starr JM (2004) Searching for genetic influences on normal cognitive ageing. Trends Cogn Sci 8, 178-184. (Pubitemid 38429928)
73. Xian X, Liu T, Yu J, Wang Y, Miao Y, Zhang J, Yu Y, Ross C, Karasinska JM, Hayden MR, Liu G, Chui D (2009) Presynaptic defects underlying impaired learning and mem-ory function in lipoprotein lipase-deficient mice. J Neurosci 29, 4681-4685.
74. Goti D, Balazs Z, Panzenboeck U, Hrzenjak A, Reicher H, Wagner E, Zechner R, Malle E, Sattler W (2002) Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alpha-tocopherol in a porcine in vitro blood-brain barrier model. J Biol Chem 277, 28537-28544. (Pubitemid 41079280)
75. Lockrow J, Prakasam A, Huang P, Bimonte-Nelson H, Sambamurti K, Granholm AC (2009) Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp Neurol 216, 278-289.
76. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F (2007) Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 50, 636-642. (Pubitemid 47442726)
77. Tsukiji T, Takahashi T, Mizobuchi S, Suzuki T, Hirakawa M, Watanabe S, Akagi R (2000) Gene expression of heme oxygenase-1 during glial activation by lipopolysac-charide. Res Commun Mol Pathol Pharmacol 107, 187-196. (Pubitemid 32666346)
78. Chavant F, Deguil J, Pain S, Ingrand I, Milin S, Fauconneau B, Perault-Pochat MC, Lafay-Chebassier C Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther 332, 505-514.
79. Rosenberg PB (2005) Clinical aspects of inflammation in Alzheimer's disease. Int Rev Psychiatry 17, 503-514. (Pubitemid 43086677)
80. Janelsins MC, Mastrangelo MA, Oddo S, LaFerla FM, Federoff HJ, Bowers WJ (2005) Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2, 23.
81. He P, Zhong Z, Lindholm K, Berning L, Lee W, Lemere C, Staufenbiel M, Li R, Shen Y (2007) Deletion of tumor necro-sis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 178, 829-841. (Pubitemid 47347367)
82. Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cog-nitive impairment. Neurobiol Aging 27, 252-261. (Pubitemid 43038549)